These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 39105082)
1. Redefining feasibility in clinical trials: Collaborative approaches for improved site selection. Bruneau B; Surdam K; Bland A; Krueger A; Wise A; Cotarlan A; Leviton A; Jouravleva E; Fitzgerald G; Frost HN; Cutler HF; Buddle J; Diaz LG; Cohen M; Sacco NA; Washington R; Mauermann S; Chen V; Bastek A Contemp Clin Trials Commun; 2024 Aug; 40():101291. PubMed ID: 39105082 [TBL] [Abstract][Full Text] [Related]
2. Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research Statement. Kurbegov D; Hurley P; Waterhouse DM; Robert NJ; Nowakowski GS; Thompson MA; Bruinooge SS; Schilsky RL; Byatt L; Dempsey K; Dawson C; Hofacker J; Liu J; MacDougall AK; Kim ES JCO Oncol Pract; 2021 Jan; 17(1):41-51. PubMed ID: 33405975 [TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
4. Clinical trials integrity: a CRO perspective. Beach JE Account Res; 2001; 8(3):245-60. PubMed ID: 12481762 [TBL] [Abstract][Full Text] [Related]
5. Clinical trial site identification practices and the use of electronic health records in feasibility evaluations: An interview study in the Nordic countries. Laaksonen N; Bengtström M; Axelin A; Blomster J; Scheinin M; Huupponen R Clin Trials; 2021 Dec; 18(6):724-731. PubMed ID: 34431408 [TBL] [Abstract][Full Text] [Related]
6. Contract research organizations in oncology clinical research: Challenges and opportunities. Roberts DA; Kantarjian HM; Steensma DP Cancer; 2016 May; 122(10):1476-82. PubMed ID: 27018651 [TBL] [Abstract][Full Text] [Related]
7. Clinical trials site recruitment optimisation: Guidance from Clinical Trials: Impact and Quality. Zahren C; Harvey S; Weekes L; Bradshaw C; Butala R; Andrews J; O'Callaghan S Clin Trials; 2021 Oct; 18(5):594-605. PubMed ID: 34041937 [TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
9. Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations. Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF Trials; 2019 Dec; 20(1):708. PubMed ID: 31829234 [TBL] [Abstract][Full Text] [Related]
10. Assessing Study Start-up Practices, Performance, and Perceptions Among Sponsors and Contract Research Organizations. Lamberti MJ; Wilkinson M; Harper B; Morgan C; Getz K Ther Innov Regul Sci; 2018 Sep; 52(5):572-578. PubMed ID: 29714558 [TBL] [Abstract][Full Text] [Related]
11. The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials. Bloom D; Beetsch J; Harker M; Hesterlee S; Moreira P; Patrick-Lake B; Selig W; Sherman J; Smith SK; Valentine JE; Roberts JN Ther Innov Regul Sci; 2018 Mar; 52(2):206-213. PubMed ID: 29714514 [TBL] [Abstract][Full Text] [Related]
12. The project data sphere initiative: accelerating cancer research by sharing data. Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994 [TBL] [Abstract][Full Text] [Related]
14. The Future of Contract Research Organizations in Dermatology and Aesthetic Research. Nestor M; Pariser D; Del Rosso J; Glaser DA; Goldberg D; Ablon G; Lorenc ZP; Santos J J Clin Aesthet Dermatol; 2022 Dec; 15(12 Suppl 1):S28-S31. PubMed ID: 36588785 [TBL] [Abstract][Full Text] [Related]
15. The Future of Contract Research Organizations in Dermatology and Aesthetic Research. Nestor M; Pariser D; Del Rosso J; Glaser DA; Goldberg D; Ablon G; Lorenc ZP; Santos J J Clin Aesthet Dermatol; 2022 Sep; 15(9):16-19. PubMed ID: 36213607 [TBL] [Abstract][Full Text] [Related]
16. Roles of contract research organizations in translational medicine. Shih MS J Orthop Translat; 2015 Apr; 3(2):85-88. PubMed ID: 30035044 [TBL] [Abstract][Full Text] [Related]
17. Exploring the divergence in perspectives on clinical trial operations in South Korea during the COVID-19 pandemic: a comparison of a trial site and sponsors. Kim YS; Kim A; Lee YS Front Med (Lausanne); 2024; 11():1342184. PubMed ID: 38510454 [TBL] [Abstract][Full Text] [Related]
18. Development and performance of the c4c national clinical trial networks for optimizing pediatric trial facilitation. Degraeuwe E; van der Geest T; Persijn L; Nuytinck L; Raes A; Turner M; Fernandes RM; Vande Walle J; de Wildt SN; Front Pediatr; 2023; 11():1302272. PubMed ID: 38188909 [TBL] [Abstract][Full Text] [Related]
19. A study of practical parameters and their relative importance as perceived by various stakeholders in clinical trials. Pant R; Joshi Y J Young Pharm; 2011 Jan; 3(1):60-4. PubMed ID: 21607056 [TBL] [Abstract][Full Text] [Related]
20. Sponsors' and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials. Perez R; Archdeacon P; Roach N; Goodwin R; Jarow J; Stuccio N; Forrest A Clin Trials; 2017 Jun; 14(3):225-233. PubMed ID: 28345368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]